Indefinite Delivery Contract 36E79720D0068

Award Date 11/1/20
Last Date to Order 3/31/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV award from the Department of Veterans Affairs (VA) National Acquisition Center is for the procurement of Aprepitant Capsules. The single-award contract has a ceiling value of $12,857,810.85 and an ordering period from November 1, 2025 to October 31, 2026, with four one-year option periods. The prime contractor is Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract aims to provide an...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Avkare LLC, a pharmaceutical and medical supply company, to provide a wide range of pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a total ceiling value of $12,991,472.85 and a period of performance from March 16, 2020 to March 15, 2025. It was awarded as a...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Golden State Medical Supply, Inc. (GSMS), a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The contract has a ceiling value of $4,547,341.50 and a period of performance ending on May 23, 2026. The IDC facilitates the provision of a wide range of pharmaceutical products to the Department of Defense (DoD), Department of Veterans Affairs (VA),...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Amgen USA Inc. for the provision of Calcitonin Gene-Related Peptide (CGRP) agents. The single-award contract has a ceiling value of $100,527,333.60 and a period of performance from February 26, 2025, to February 25, 2026, with four one-year option periods. The contract aims to provide an uninterrupted source of supply for CGRP products to the VA, including its...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Cipla USA Inc., a foreign-owned, for-profit pharmaceutical company, to supply ambrisentan tablets. The $9,494,690 single-award contract has a period of performance from April 1, 2021 to March 31, 2022, with four one-year option periods. The ambrisentan tablets are a specialty drug that requires pharmacies to enroll in the FDA's Ambrisentan Shared System Risk Evaluation...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a division of the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract has a ceiling value of $18,098,362.00 and a period of performance from March 2, 2021 to March 1, 2026. The contract is for the delivery of Pregabalin capsules, a generic pharmaceutical product, to the VA,...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products. The contract has a ceiling value of $8,612,710.75 and covers the supply of mycophenolic acid tablets in 180mg and 360mg strengths to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). This single-award IDC has...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted IDC has a ceiling value of $4,792,297.44 and a period of performance through December 19, 2025. The contract covers the delivery of a variety of generic pharmaceutical products, including Dofetilide Capsules, to the VA, Department of...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals. The contract has a ceiling value of $1,500,109.20 and a period of performance from February 19, 2023 to August 18, 2025, with four one-year option periods. The contract aims to procure Perphenazine tablets in various strengths for the VA, Department of Defense (DoD), Bureau of...

This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Glenmark Pharmaceuticals Inc., USA, a foreign-owned, for-profit pharmaceutical company. The contract has a total ceiling value of $2,635,810 and a period of performance from November 1, 2020 through October 31, 2021, with four one-year option periods.

The purpose of this IDC is to provide an uninterrupted source of supply for aprepitant capsules to serve the pharmaceutical needs of the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The contract items will be distributed through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. The contracted products include various package sizes and strengths of aprepitant capsules, with estimated annual usage quantities provided in the original solicitation. This contract leverages Glenmark's existing federal supply schedule and IDC vehicles to supply branded and generic pharmaceutical products to key federal healthcare agencies.

Generated 4/11/25, 11:31 AM